Trials / Active Not Recruiting
Active Not RecruitingNCT06189183
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection-Single Center Phase II Single Arm Clinical Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.
Detailed description
Adjuvant Radiotherapy(Postoperative radiotherapy) is proposed in stage II and III thymic carcinoma，stage III thymoma，stage IIB B2/B3 thymomas. Hypofractionation Radiotherapy is used in this study. The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Adjuvant Hypofractionation Radiotherapy | Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection |
Timeline
- Start date
- 2023-11-11
- Primary completion
- 2030-12-31
- Completion
- 2040-12-31
- First posted
- 2024-01-03
- Last updated
- 2026-04-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06189183. Inclusion in this directory is not an endorsement.